Merck (MRK) Total Non-Current Liabilities (2016 - 2025)
Merck (MRK) has disclosed Total Non-Current Liabilities for 14 consecutive years, with $76.5 billion as the latest value for Q4 2025.
- On a quarterly basis, Total Non-Current Liabilities changed N/A to $76.5 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $76.5 billion, a N/A change, with the full-year FY2025 number at $76.5 billion, changed N/A from a year prior.
- Total Non-Current Liabilities was $76.5 billion for Q4 2025 at Merck, up from -$55.1 billion in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $76.5 billion in Q4 2025 to a low of -$55.1 billion in Q1 2025.
- A 5-year average of $2.0 billion and a median of $600.0 million in 2022 define the central range for Total Non-Current Liabilities.
- Peak YoY movement for Total Non-Current Liabilities: skyrocketed 100.0% in 2022, then tumbled 7440.67% in 2025.
- Merck's Total Non-Current Liabilities stood at $400.0 million in 2021, then skyrocketed by 50.0% to $600.0 million in 2022, then changed by 0.0% to $600.0 million in 2023, then rose by 25.0% to $750.0 million in 2024, then surged by 10102.13% to $76.5 billion in 2025.
- Per Business Quant, the three most recent readings for MRK's Total Non-Current Liabilities are $76.5 billion (Q4 2025), -$55.1 billion (Q1 2025), and $750.0 million (Q2 2024).